Organogenesis Holdings Inc.
ORGO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $421 | $537 | $350 | $1,186 |
| - Cash | $136 | $104 | $102 | $114 |
| + Debt | $43 | $119 | $124 | $132 |
| Enterprise Value | $329 | $552 | $371 | $1,204 |
| Revenue | $482 | $433 | $451 | $467 |
| % Growth | 11.3% | -3.9% | -3.5% | – |
| Gross Profit | $366 | $327 | $346 | $353 |
| % Margin | 76% | 75.4% | 76.7% | 75.6% |
| EBITDA | $16 | $36 | $40 | $87 |
| % Margin | 3.3% | 8.3% | 8.9% | 18.6% |
| Net Income | $1 | $5 | $16 | $94 |
| % Margin | 0.2% | 1.1% | 3.4% | 20.2% |
| EPS Diluted | 0.007 | 0.037 | 0.12 | 0.7 |
| % Growth | -82.6% | -68.9% | -82.9% | – |
| Operating Cash Flow | $14 | $31 | $25 | $62 |
| Capital Expenditures | -$10 | -$24 | -$34 | -$31 |
| Free Cash Flow | $4 | $7 | -$9 | $31 |